TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 5.00E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 5.30E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 6.00E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 7.70E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 7.90E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 8.30E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 8.70E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 9.60E+3nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info
TargetGamma-aminobutyric acid receptor subunit alpha-1(Rattus norvegicus (Rat))
Algiax Pharmaceuticals
US Patent
Algiax Pharmaceuticals
US Patent
Affinity DataIC50: 1.03E+4nMAssay Description:Standard assays were carried out to measure the effects of these compounds on the cytotoxicity, virus yield and infection rates of 2019-nCoVs. Firstl...More data for this Ligand-Target Pair
Ligand Info